Grow Everything Biotech Podcast 53. From Microbes to Mega Ventures: 'Brewing Success with 2048 Ventures' Julie Wolf
12 snips
Dec 1, 2023 Julie Wolf, a microbiologist-turned-VC at 2048 Ventures who builds biotech infrastructure and platform investments. She discusses investing in bioproduction and synthetic biology. They explore DNA synthesis and biosecurity, AI in omics and microscopy, and what founders need to scale and attract funding.
AI Snips
Chapters
Transcript
Episode notes
From PhD To VC Through Community Labs
- Julie traced her path from a PhD in microbiology to science communication, community labs, a startup, IndieBio and finally VC at 2048 Ventures.
- She credits hands-on teaching at Genspace and running Brooklyn Bio for shaping her venture focus.
Invest In Biotech Infrastructure First
- 2048 focuses on infrastructure, platform and API companies because those build the sector's backbone and accelerate many downstream startups.
- Infrastructure spans hardware, strains, sensors and computational layers for scale and reliability.
Omics Data Needs AI To Unlock Value
- Omics plus AI creates valuable datasets that can drive diagnostics, target discovery and trial selection.
- Proprietary high-throughput data combined with compute unlocks signals hidden in biological haystacks.